Showing results (171-180 of 382) with videos related to

Sort By:
Pageof 39
Plos Biology|February 4, 2010
PINK1 is selectively stabilized on impaired mitochondria to activate ParkinDerek P Narendra, Seok Min Jin, Atsushi Tanaka, et al.
Neuroscience Letters|January 17, 2009
Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson diseaseJeff Blackinton, Ravindran Kumaran, Marcel P van der Brug, et al.
Neuroscience Letters|January 25, 2005
Unaltered alpha-synuclein blood levels in juvenile Parkinsonism with a parkin exon 4 deletionDavid W Miller, Anthony Crawley, Katrina Gwinn-Hardy, et al.
The Biochemical Journal|March 22, 2017
The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2Iakov N Rudenko, Alice Kaganovich, Rebekah G Langston, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Integrative analysis reveals generalizable human neurodegenerative disease-associated glial statesLiam Horan-Portelance, Dominic J Acri, Alexandra Mann, et al.
Bioengineering (Basel, Switzerland)|January 28, 2026
A Xeno-Free Protocol for Rapid Differentiation of Human iPSC-Derived Microglia from the KOLF2.1J Reference LineNélio A J Oliveira, Katherine R Lewkowicz, Patricia A Clow, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2013
Lysosomal impairment in Parkinson's diseaseBenjamin Dehay, Marta Martinez-Vicente, Guy A Caldwell, et al.
Neurogenetics|April 10, 2017
Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson's disease on chromosome 7p15.3Megha N Murthy, Cornelis Blauwendraat, , et al.
Plos Genetics|January 5, 2011
Cancer and neurodegeneration: between the devil and the deep blue seaHélène Plun-Favreau, Patrick A Lewis, John Hardy, et al.
Brain Research|April 29, 2021
In silico comparative analysis of LRRK2 interactomes from brain, kidney and lungAmrita Verma, Kirsten Ebanks, Chi-Yee Fok, et al.
Pageof 39